Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exergaming and Mediterranean Diet in Thyroid Cancer Patients Post-Thyroidectomy
NCT05265819Completed
- Start
- Mar 2022
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
Randomised, open-label trial in thyroid cancer (4 arms). Primary endpoints: CD3- Natural Killer Cells at 3 months, CD16+ Natural Killer Cells at 3 months and 1 more. Started Mar 2022; status: completed.
02
Conditions
thyroid cancer
Beyond the preview
Go deeper on NCT05265819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05265819.